Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome

Lipids

Volumn 48, Issue 6, 2013, Pages 557-567

  Andersen, Catherine J ^a   Blesso, Christopher N ^a,b   Lee, Jiyoung ^a   Barona, Jacqueline ^a,c   Shah, Dharika ^b   Thomas, Michael J ^b   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Carbohydrate restricted diet; Cholesterol efflux; Eggs; HDL; Metabolic syndrome; Phospholipids

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; SPHINGOMYELIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CELL TRANSPORT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EGG; EGG YOLK; FEMALE; FOOD INTAKE; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; MACROPHAGE; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BODY WEIGHT; CHOLESTEROL, HDL; DIET, CARBOHYDRATE-RESTRICTED; EGG YOLK; EGGS; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHOLIPIDS;

EID: 84878581646     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3780-8     Document Type: Article

References (62)

1. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH (2008) The metabolic syndrome. Endocr Rev 29:777-822
2. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH (2009) The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 50(Suppl):S189-S194
3. Asztalos BF, Tani M, Schaefer EJ (2011) Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol 22:176-185
4. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res 95:764-772
5. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127-135
6. Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342-374
7. Tchoua U, Gillard BK, Pownall HJ (2010) HDL superphospholipidation enhances key steps in reverse cholesterol transport. Atherosclerosis 209:430-435
8. Fournier N, Paul JL, Atger V, Cogny A, Soni T, de la Llera-Moya M, Rothblat G, Moatti N (1997) HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 17:2685-2691
9. Rosenson RS, Brewer HB Jr, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ (2011) HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem 57:392-410
10. Dashti M, Kulik W, Hoek F, Veerman EC, Peppelenbosch MP, Rezaee F (2011) A phospholipidomic analysis of all defined human plasma lipoproteins. Sci Rep 1:139
11. Zhang W, Asztalos B, Roheim PS, Wong L (1998) Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I. J Lipid Res 39:1601-1607
12. Piperi C, Kalofoutis C, Papaevaggeliou D, Papapanagiotou A, Lekakis J, Kalofoutis A (2004) The significance of serum HDL phospholipid levels in angiographically defined coronary artery disease. Clin Biochem 37:377-381
13. Bovet P, Darioli R, Essinger A, Golay A, Sigwart U, Kappenberger L (1989) Phospholipids and other lipids in angiographically assessed coronary artery disease. Atherosclerosis 80:41-47
14. Fournier N, de la Llera Moya M, Burkey BF, Swaney JB, Paterniti J Jr, Moatti N, Atger V, Rothblat GH (1996) Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res 37:1704-1711
15. Mweva S, Paul JL, Cambillau M, Goudouneche D, Beaune P, Simon A, Fournier N (2006) Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity. Eur J Clin Invest 36:552-559
16. Klimov AN, Konstantinov VO, Lipovetsky BM, Kuznetsov AS, Lozovsky VT, Trufanov VF, Plavinsky SL, Gundermann KJ, Schumacher R (1995) "Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. Cardiovasc Drugs Ther 9:779-784
17. Bunea R, El Farrah K, Deutsch L (2004) Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 9:420-428
18. Mutungi G, Ratliff J, Puglisi M, Torres-Gonzalez M, Vaishnav U, Leite JO, Quann E, Volek JS, Fernandez ML (2008) Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. J Nutr 138:272-276
19. Iwata T, Hoshi S, Takehisa F, Tsutsumi K, Furukawa Y, Kimura S (1992) The effect of dietary safflower phospholipid and soybean phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet. J Nutr Sci Vitaminol (Tokyo) 38:471-479
20. Wat E, Tandy S, Kapera E, Kamili A, Chung RW, Brown A, Rowney M, Cohn JS (2009) Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 205:144-150
21. Kullenberg D, Taylor LA, Schneider M, Massing U (2012) Health effects of dietary phospholipids. Lipids Health Dis 11:3
22. Zierenberg O, Grundy SM (1982) Intestinal absorption of polyenephosphatidylcholine in man. J Lipid Res 23:1136-1142
23. Weihrauch JL, Son Y-S (1983) The phospholipid content of foods. J Am Oil Chem Soc 60:1971-1978
24. Cohn JS, Kamili A, Wat E, Chung RW, Tandy S (2010) Dietary phospholipids and intestinal cholesterol absorption. Nutrients 2:116-127
25. Mutungi G, Waters D, Ratliff J, Puglisi M, Clark RM, Volek JS, Fernandez ML (2010) Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem 21:261-267
26. Blesso CN, Andersen CJ, Barona J, Volek JS, Fernandez ML (2013) Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome. Metabolism 62:400-410
27. Blesso CN, Andersen CJ, Bolling BW, Fernandez ML (2013) Egg intake improves carotenoid status by increasing plasma HDL cholesterol in adults with metabolic syndrome. Food Funct 31:213-221
28. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89:4963-4971
29. (2001) Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
30. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13-e18
31. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
32. Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ (2012) Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J Lipid Res 53:1890-1909
33. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
34. Mayurasakorn K, Srisura W, Sitphahul P, Hongto PO (2008) High-density lipoprotein cholesterol changes after continuous egg consumption in healthy adults. J Med Assoc Thai 91:400-407
35. Klein BE, Klein R, Lee KE (2002) Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25:1790-1794
36. Hong Y, Jin X, Mo J, Lin HM, Duan Y, Pu M, Wolbrette DL, Liao D (2007) Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all - cause mortality-results of prospective analysis for the atherosclerosis risk in communities study. J Intern Med 262:113-122
37. Shuhei N, Soderlund S, Jauhiainen M, Taskinen MR (2010) Effect of HDL composition and particle size on the resistance of HDL to the oxidation. Lipids Health Dis 9:104
38. Park KH, Shin DG, Kim JR, Hong JH, Cho KH (2010) The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Int J Mol Med 25:129-136
39. Parra ES, Urban A, Panzoldo NB, Nakamura RT, Oliveira R, de Faria EC (2011) A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women. Lipids Health Dis 10:87
40. Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, Lewis GF (1999) Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 103:1191-1199
41. Skeggs JW, Morton RE (2002) LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J Lipid Res 43:1264-1274
42. Kinoshita M, Fujita M, Usui S, Maeda Y, Kudo M, Hirota D, Suda T, Taki M, Okazaki M, Teramoto T (2004) Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL. Atherosclerosis 173:197-202
43. Arsenault BJ, Lemieux I, Despres JP, Gagnon P, Wareham NJ, Stroes ES, Kastelein JJ, Khaw KT, Boekholdt SM (2009) HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis 206:276-281
44. Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, Kraemer WJ, Bibus DM, Fernandez ML, Feinman RD (2009) Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 44:297-309
45. Smirnov MD, Esmon CT (1994) Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 269:816-819
46. Griffin JH, Kojima K, Banka CL, Curtiss LK, Fernandez JA (1999) High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 103:219-227
47. Bradamante S, Barenghi L, Giudici GA, Vergani C (1992) Free radicals promote modifications in plasma high-density lipoprotein: nuclear magnetic resonance analysis. Free Radic Biol Med 12:193-203
48. Navab M, Hama S, Hough G, Fogelman AM (2003) Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation 108:1735-1739
49. Wang H, Du J, Lu S, Yao Y, Hunter F, Black DD (2001) Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine. Lipids 36:683-687
50. Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F, Hayden MR (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 116:1052-1062
51. Rachmilewitz D, Fainaru M (1979) Apolipoprotein A-I synthesis and secretion by cultured human intestinal mucosa. Metabolism 28:739-743
52. Xu M, Zhou H, Gu Q, Li C (2009) The expression of ATP-binding cassette transporters in hypertensive patients. Hypertens Res 32:455-461
53. Xu M, Zhou H, Wang J, Li C, Yu Y (2009) The expression of ATP-binding cassette transporter A1 in Chinese overweight and obese patients. Int J Obes (Lond) 33:851-856
54. Nakanishi S, Vikstedt R, Soderlund S, Lee-Rueckert M, Hiukka A, Ehnholm C, Muilu M, Metso J, Naukkarinen J, Palotie L, Kovanen PT, Jauhiainen M, Taskinen MR (2009) Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity. J Lipid Res 50:183-192
55. Gantman A, Fuhrman B, Aviram M, Hayek T (2010) High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx. Biochem Biophys Res Commun 391:523-528
56. Wang X, Liao D, Bharadwaj U, Li M, Yao Q, Chen C (2008) C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 28:519-526
57. Ervin RB (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report:1-7
58. Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A (2008) Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. Eur J Endocrinol 158:53-60
59. Alenezi MY, Marcil M, Blank D, Sherman M, Genest J Jr (2004) Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect? J Clin Endocrinol Metab 89:761-764
60. Duong M, Collins HL, Jin W, Zanotti I, Favari E, Rothblat GH (2006) Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 26:541-547
61. Jian B, de la Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH (1998) Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 273:5599-5606
62. Aron-Wisnewsky J, Julia Z, Poitou C, Bouillot JL, Basdevant A, Chapman MJ, Clement K, Guerin M (2011) Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab 96:1151-1159